Agonist-specific regulation of μ-opioid receptor desensitization and recovery from desensitization

Molecular Pharmacology

Volumn 73, Issue 4, 2008, Pages 1301-1308

  Virk, Michael S ^a   Williams, John T ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORNALTREXAMINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ETORPHINE; FENTANYL; METENKEPHALIN; METHADONE; MORPHINE; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR; OPIATE AGONIST; OXYCODONE; OXYMORPHONE;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DESENSITIZATION; LOCUS CERULEUS; MALE; NONHUMAN; POTASSIUM CURRENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; RAT; RECORDING; VOLTAGE CLAMP;

ANALGESICS, OPIOID; ANIMALS; DOWN-REGULATION; ELECTROPHYSIOLOGY; ENKEPHALINS; ETORPHINE; FENTANYL; MALE; NALTREXONE; OXYMORPHONE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, MU;

EID: 41149178141     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.042952     Document Type: Article

References (34)

1. Alvarez VA, Arttamangkul S, Dang V, Salem A, Whistler JL, Von Zastrow M, Grandy DK, and Williams JT (2002) mu-Opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization. J Neurosci 22:5769-5776.
2. Arttamangkul S, Torrecilla M, Kobayashi K, Okano H, and Williams JT (2006) Separation of mu opioid receptor desensitization and internalizations. Endogenous receptors in primary neuronal cultures. J Neurosci 26:4118-4125.
3. Avidor-Reiss T, Nevo I, Saya D, Bayewitch M, and Vogel Z (1997) Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem 272:5040-5047.
4. Bailey CP and Connor M (2005) Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5:60-68.
5. Bohn LM, Gainetdinov RR, Lin FT, Lefkowitz RJ, and Caron MG (2000) Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 408:720-723.
6. Borgland SL, Connor M, Osborne PB, Furness JB, and Christie MJ (2003) Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors. J Biol Chem 278:18776-18784.
7. Celver J, Xu M, Jin W, Lowe J, and Chavkin C (2004) Distinct domains of the μ-opioid receptor control uncoupling and internalization. Mol Pharmacol 65:528-537.
8. Christie MJ, Williams JT, and North RA (1986) Tolerance to opioids in single locus coeruleus neurons of the rat. NIDA Res Monogr 75:591-594.
9. Connor M, Osborne PB, and Christie MJ (2004) Mu-opioid receptor desensitization: is morphine different? Br J Pharmacol 143:685-696.
10. Dang VC and Williams JT (2004) Chronic morphine treatment reduces recovery from opioid desensitization. J Neurosci 24:7699-7706.
11. Dang VC and Williams JT (2005) Morphine-induced μ-opioid receptor desensitization. Mol Pharmacol 68:1127-1132.
12. Fiorillo CD and Williams JT (1996) Opioid desensitization: interactions with Gprotein-coupled receptors in the locus coeruleus. J Neurosci 16:1479-1485.
13. Grecksch G, Bartzsch K, Widera A, Becker A, Hollt V, and Koch T (2006) Development of tolerance and sensitization to different opioid agonists in rats. Psychopharmacology (Berl) 186:177-184.
14. Harris GC and Williams JT (1991) Transient homologous mu-opioid receptor desensitization in rat locus coeruleus neurons. J Neurosci 11:2574-2581.
15. Johnson EA, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall KJ, Mundell SJ, Bailey CP, Kelly E, and Henderson G (2006) Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells. Mol Pharmacol 70:676-685.
16. Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart PL, Evans CJ, and von Zastrow M (1998) mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 53:377-384.
17. Koch T, Brandenburg LO, Liang Y, Schulz S, Beyer A, Schroder H, and Hollt V (2004) Phospholipase D2 modulates agonist-induced mu-opioid receptor desensitization and resensitization. J Neurochem 88:680-688.
18. Koch T, Widera A, Bartzsch K, Schulz S, Brandenburg LO, Wundrack N, Beyer A, Grecksch G, and Hollt V (2005) Receptor endocytosis counteracts the development of opioid tolerance. Mol Pharmacol 67:280-287.
19. Law PY, Erickson LJ, El-Kouhen R, Dicker L, Solberg J, Wang W, Miller E, Burd AL, and Loh HH (2000) Receptor density and recycling affect the rate of agonist-induced desensitization of μ-opioid receptor. Mol Pharmacol 58:388-398.
20. Lemberg KK, Kontinen VK, Siiskonen AO, Viljakka KM, Yli-Kauhaluoma JT, Korpi ER, and Kalso EA (2006) Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats. Anesthesiology 105:801-812.
21. Osborne PB and Williams JT (1995) Characterization of acute homologous desensitization of mu-opioid receptor-induced currents in locus coeruleus neurones. Br J Pharmacol 115:925-932.
22. Patel MB, Patel CN, Rajashekara V, and Yoburn BC (2002) Opioid agonists differentially regulate μ-opioid receptors and trafficking proteins in vivo. Mol Pharmacol 62:1464-1470.
23. Pawar M, Kumar P, Sunkaraneni S, Sirohi S, Walker EA, and Yoburn BC (2007) Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2. Eur J Pharmacol 563:92-101.
24. Peckham EM and Traynor JR (2006) Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats. J Pharmacol Exp Ther 316:1195-1201.
25. Schulz S, Mayer D, Pfeiffer M, Stumm R, Koch T, and Hollt V (2004) Morphine induces terminal micro-opioid receptor desensitization by sustained phosphorylation of serine-375. EMBO J 23:3282-3289.
26. Stafford K, Gomes AB, Shen J, and Yoburn BC (2001) mu-Opioid receptor down-regulation contributes to opioid tolerance in vivo. Pharmacol Biochem Behav 69:233-237.
27. von Zastrow M (2004) A cell biologist's perspective on physiological adaptation to opiate drugs. Neuropharmacology 47 (Suppl 1):286-292.
28. Walker EA and Young AM (2001) Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats. Psychopharmacology (Berl) 154:131-142.
29. Whistler JL, Chuang HH, Chu P, Jan LY, and von Zastrow M (1999) Functional dissociation of mu opioid receptor signaling and endocytosis: implications for the biology of opiate tolerance and addiction. Neuron 23:737-746.
30. Whistler JL and von Zastrow M (1998) Morphine-activated opioid receptors elude desensitization by β-arrestin. Proc Natl Acad Sci U S A 95:9914-9919.
31. Williams JT, Christie MJ, and Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343.
32. Williams JT, North RA, Shefner SA, Nishi S, and Egan TM (1984) Membrane properties of rat locus coeruleus neurones. Neuroscience 13:137-156.
33. Yu Y, Zhang L, Yin X, Sun H, Uhl GR, and Wang JB (1997) μ-Opioid receptor phosphorylation, desensitization, and ligand efficacy. J Biol Chem 272:28869-28874.
34. Zhang J, Ferguson SS, Barak LS, Aber MJ, Giros B, Lefkowitz RJ, and Caron MG (1997) Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization. Receptors Channels 5:193-199.